| CAS ID: | 242138-07-4 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Monoclonal antibody |
| Natural Product: | No |
| Other Names: | OMALIZUMAB | XOLAIR | IGE25 | OLIZUMAB | RHUMAB-E25 | RG-3648 |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT00787917 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Terminated |
| First Received | November 10, 2008 | Last Verified | September 26, 2011 |
| Sponsor | Novartis Pharmaceuticals | ||
| PubChem: | 47206967 |
| ChEMBL: | CHEMBL1201589 |